CSIMarket


Renalytix Plc  (RNLX)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare


 

Renalytix Plc

RNLX's Financial Statements and Analysis



Renalytix Plc reported in the first quarter of 2024 net loss per share of $-0.11 compare to earnings per share of $0.00 in the same quarter a year ago a decrease compare to $0.00 realized in previous quarter.


first quarter of 2024
Earnings Per Share Revenues
$ -0.11 $  0 Mill
$-0.11     Unch.    



Renalytix Plc's Revenue rose by 0 % in first quarter of 2024 (Sep 30 2023) year on year, to $0 million and declined by -86.51 % sequentially.


Renalytix Plc is

More on RNLX's Income Statement



Renalytix Plc in the first quarter of 2024 recorded net loss of $-10.154 million, compare to net income of $0.000 million achieved in II. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-45.607 million realized in previous quarter.

More on RNLX's Growth

Renalytix Plc Inventories
In Sep 30 2023 company's net cash and cash equivalents decreased by $-11 million


Renalytix Plc does not pay out common stock dividend.

In trailing twelve-month period Renalytix Plc payed $ -0.46 cash per share, on a free-cash flow basis .




Company issued 11.85 million shares or 14.29 % in Sep 30 2023.


More on RNLX's Dividends

 Market Capitalization (Millions) 40
 Shares Outstanding (Millions) 95
 Total Debt (Millions $) 10
 Revenue (TTM) (Millions $) 7
 Net Income (TTM) (Millions $) -101
 Cash Flow (TTM) (Millions $) -27
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Renalytix Plc does not pay out common stock dividend.

In trailing twelve-month period Renalytix Plc had negative $ -0.46 cash flow per share, on a free-cash flow basis .




Company issued 11.85 million shares or 14.29 % in Sep 30 2023.


More on RNLX's Balance Sheets

 Market Capitalization (Millions) 40
 Shares Outstanding (Millions) 95
 Total Debt (Millions $) 10
 Revenue (TTM) (Millions $) 7
 Net Income (TTM) (Millions $) -101
 Cash Flow (TTM) (Millions $) -27
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -
   


  News about Renalytix Plc Earnings